MedInfo World

Empowering patients through shared knowledge and community-driven health insights.

Platform

Drug Information
Health Conditions
Active Ingredients

Support

Help Center
Terms of Use
Privacy Policy
Disclaimer

Company

About Us
Contact

Medical Disclaimer

The information on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Terms Privacy Disclaimer

Mogamulizumab – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.

Home Active IngredientsMogamulizumab

Mogamulizumab

Chemokine Receptor Type 4 Interaction [EPC]

1 Drug1 Variant

Clinical Data

Name

Mogamulizumab

Raw Name

MOGAMULIZUMAB

Drug Classes

Chemokine Receptor Type 4 Interaction [EPC]Monoclonal Antibody [EPC]

Important Notice

This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Mogamulizumab.

Mechanism of Action

Chemokine Receptor Type 4 Interactions [MoA]

Chemical Structure

Antibodies, Monoclonal [CS]

Identifiers

RxCUI

2054081, 2054086

UNII

YI437801BE

Drugs with Mogamulizumab

Medications containing this ingredient

Poteligeo